The DnaK chaperone system buffers the fitness cost of antibiotic resistance mutations in mycobacteria Journal Article


Authors: Fay, A.; Philip, J.; Saha, P.; Hendrickson, R. C.; Glickman, M. S.; Burns-Huang, K.
Article Title: The DnaK chaperone system buffers the fitness cost of antibiotic resistance mutations in mycobacteria
Abstract: Chaperones aid in protein folding and maintenance of protein integrity. In doing so, they have the unique ability to directly stabilize resistance-conferring amino acid substitutions in drug targets and to counter the stress imparted by these substitutions, thus supporting heritable antimicrobial resistance (AMR). We asked whether chaperones support AMR in Mycobacterium smegmatis, a saprophytic model of Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). We show that DnaK associates with many drug targets and that DnaK associates more with AMR-conferring mutant RNA polymerase (RNAP) than with wild-type RNAP. In addition, fre-quency-of-resistance (FOR) and fitness studies reveal that the DnaK system of chaperones supports AMR in antimicrobial targets in mycobacteria, including RNAP and the ribosome. These findings highlight chaperones as potential targets for drugs to over-come AMR in mycobacteria, including M. tuberculosis, as well as in other pathogens. IMPORTANCE AMR is a global problem, especially for TB. Here, we show that myco-bacterial chaperones support AMR in M. smegmatis, a nonpathogenic model of M. tu-berculosis, the causative agent of TB. In particular, the mycobacterial DnaK system of chaperones supports AMR in the antimicrobial targets RNA polymerase and the ribo-some. This is the first report showing a role for protein chaperones in mediating AMR in mycobacteria. Given the widespread role of protein chaperones in enabling genomic diversity, we anticipate that our findings can be extended to other microbes. © 2021 Fay et al.
Keywords: mycobacteria; antimicrobial resistance; dnak; protein chaperone
Journal Title: mBio
Volume: 12
Issue: 2
ISSN: 2150-7511
Publisher: American Society for Microbiology  
Date Published: 2021-03-30
Start Page: e00123-21
Language: English
DOI: 10.1128/mBio.00123-21
PUBMED: 33785614
PROVIDER: scopus
PMCID: PMC8092207
DOI/URL:
Notes: Article -- Export Date: 3 May 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Allison J Fay
    15 Fay
  2. Michael Glickman
    110 Glickman
  3. John Philip
    48 Philip